Gelonghui, May 13, 丨 Jun Yao Health (605388.SH) said on an interactive platform that the company is closely following industry trends and related developments. Biomaneling is a new track and new business format where new quality productivity is very important, and the field of synthetic biology has also received a lot of attention from the market. As a practitioner of the big health industry layout, the company closely revolves around the vision of “being a global probiotic leader” and has achieved many domestic breakthroughs in the field of probiotics based on scientific research and technological breakthroughs. In 2023, the company's probiotic strain library increased by more than 140 strains, optimized the fermentation process for more than 40 strains, and added more than 60 new starter strains; the production of the main products, fermentants and probiotics, achieved a three-digit increase. Currently, the company has no relevant layout in the field of synthetic biology. In the future, the company will closely track and evaluate industry trends, combine its competitive advantages, and proactively seize growth opportunities.